WallStreetZenWallStreetZen

NASDAQ: FGEN
Fibrogen Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their FGEN stock forecasts and price targets.

Forecast return on equity

Is FGEN forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is FGEN forecast to generate an efficient return on assets?
Company
N/A
Industry
31.03%

FGEN earnings per share forecast

What is FGEN's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.05
Avg 2 year Forecast
-$0.33

FGEN revenue forecast

What is FGEN's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$157.0M-6.26%
Avg 2 year Forecast
$145.0M-13.43%
FGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FGEN revenue growth forecast

How is FGEN forecast to perform vs Biotechnology companies and vs the US market?
Company
6.47%
Industry
65.53%
Market
11.49%
FGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FGEN$1.14N/AN/A
RLMD$3.77$2.00-46.95%Strong Sell
COYA$7.67$16.00+108.60%Strong Buy
ADAG$2.60$5.00+92.31%Buy
AEON$2.86$6.00+109.79%Buy

Fibrogen Stock Forecast FAQ

What is FGEN's earnings growth forecast for 2024-2025?

(NASDAQ: FGEN) Fibrogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.86%.

Fibrogen's earnings in 2024 is -$240,460,000.On average, 2 Wall Street analysts forecast FGEN's earnings for 2024 to be -$104,449,168, with the lowest FGEN earnings forecast at -$127,328,509, and the highest FGEN earnings forecast at -$81,569,826.

In 2025, FGEN is forecast to generate -$32,826,881 in earnings, with the lowest earnings forecast at -$80,575,072 and the highest earnings forecast at $14,921,310.

If you're new to stock investing, here's how to buy Fibrogen stock.

What is FGEN's revenue growth forecast for 2024-2025?

(NASDAQ: FGEN) Fibrogen's forecast annual revenue growth rate of 6.47% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.49%.

Fibrogen's revenue in 2024 is $167,493,000.On average, 1 Wall Street analysts forecast FGEN's revenue for 2024 to be $15,617,637,486, with the lowest FGEN revenue forecast at $15,617,637,486, and the highest FGEN revenue forecast at $15,617,637,486.

In 2025, FGEN is forecast to generate $14,423,932,710 in revenue, with the lowest revenue forecast at $14,423,932,710 and the highest revenue forecast at $14,423,932,710.

What is FGEN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FGEN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.03%.

What is FGEN's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: FGEN) Fibrogen's current Earnings Per Share (EPS) is -$2.45. On average, analysts forecast that FGEN's EPS will be -$1.05 for 2024, with the lowest EPS forecast at -$1.28, and the highest EPS forecast at -$0.82. In 2025, FGEN's EPS is forecast to hit -$0.33 (min: -$0.81, max: $0.15).

What is FGEN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FGEN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.